Quantitation and characterization of anti‐Galα1–3Gal antibodies in sera of 200 healthy persons

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Xenotransplantation

• Publication date

  1999-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1034/J.1399-3089.1999.00023.XPMID 10503783
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural studies on the hexose region of the core in lipopolysaccharides from Enterobacteriaceae.

  2005cited by this paper
• Xenogeneic transplantation.

  1998cited by this paper
• Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model.

  1998cited by this paper
• Rapid and sensitive GC/MS characterization of glycolipid released Galalpha1,3Gal-terminated oligosaccharides from small organ specimens of a single pig.

  1998cited by this paper
• Polymorphism in the human anti-pig natural antibody repertoire: implications for antigen-specific immunoadsorption.

  1998cited by this paper
• The histo‐blood group ABO system and tissue transplantation

  1998cited by this paper
• Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal(alpha1,3)Galactose epitope.

  1997cited by this paper
• Characterization of porcine platelet glycoproteins recognized by human natural "anti-gal" antibodies.

  1996cited by this paper
• Polymer-immobilized carbohydrate ligands: versatile chemical tools for biochemistry and medical sciences

  1996cited by this paper
• Quantitative evaluation of porcine endothelial cell antigens recognized by human natural antibodies: An analysis by Western blotting

  1996cited by this paper
• Detection, immunoabsorption, and inhibition of cytotoxic activity of anti‐αGal antibodies using newly developed substances with synthetic Gal α1–3Gal disaccharide epitopes

  1995cited by this paper
• Characterization and affinity isolation of xenoreactive human natural antibodies.

  1994cited by this paper
• Natural Antibodies and Human Xenotransplantation

  1994cited by this paper
• Variation in expression of porcine xenogeneic antigens.

  1994cited by this paper
• Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody.

  1993cited by this paper
• One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody.

  1993cited by this paper
• Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes.

  1993cited by this paper
• Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans.

  1992cited by this paper
• Antibodies against galactosyl (α1→3) galactose in connective tissue diseases

  1991cited by this paper
• Single-unit transfusions of RBC enzymatically converted from group B to group O to A and O normal volunteers.

  1991cited by this paper
• Antibodies to histo‐blood group substances A and B: agglutination titers, Ig class, and IgG subclasses in healthy persons of different age categories

  1991cited by this paper
• Antibodies against galactosyl (alpha 1----3) galactose in connective tissue diseases.

  1991cited by this paper
• Novel O-linked carbohydrate chains in the cellulase complex (cellulosome) of Clostridium thermocellum. 3-O-Methyl-N-acetylglucosamine as a constituent of a glycoprotein.

  1989cited by this paper
• Immunogenic Gal alpha 1----3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania.

  1989cited by this paper
• Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora

  1988cited by this paper
• Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells.

  1988cited by this paper
• Immunochemistry of I/i-active oligo- and polyglycosylceramides from rabbit erythrocyte membranes. Characterization of linear, di-, and triantennary neolactoglycosphingolipids.

  1985cited by this paper
• Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues

  1985cited by this paper
• Structural studies of the Klebsiella O group 8 lipopolysaccharide.

  1973cited by this paper
• Structural studies on Klebsiella O groups 1 and 6 lipopolysaccharides.

  1971cited by this paper
• Chemistry of lipid of the posthemyolytic residue or stroma of erythrocytes. XVI. Occurrence of ceramide pentasaccharide in the membrane of erythrocytes and reticulocytes of rabbit.

  1968cited by this paper
• The immunochemistry of Salmonella chemotype VI O-antigens. The structure of oligosaccharides from Salmonella group U (o 43) lipopolysaccharides.

  1965cited by this paper

• Alpha-gal sensitization and allergic blood transfusion reactions: a scoping review.

  2026cites this paper
• The Level of Antibodies to Tumor-Associated Glycans in Gastric Cancer Patients Is Lower than in Healthy Donors and Reduces with Age

  2026cites this paper
• Impact of Staphylococcus aureus colonization and skin abscesses on formation of human anti-αGal antibodies

  2025cites this paper
• IgG to Galactose-Alpha-1,3-Galactose: Impact of Alpha-Gal IgE Sensitization, Blood Type, and Tick Bites

  2025cites this paper
• A general and accessible approach to enrichment and characterisation of natural anti-Neu5Gc antibodies from human samples

  2025cites this paper
• A systematic review reveals conflicting evidence for the prevalence of antibodies against the sialic acid ‘xenoautoantigen’ Neu5Gc in humans and the need for a standardised approach to quantification

  2024cites this paper
• COVID-19 and Preparing Planetary Health for Future Ecological Crises: Hopes from Glycomics for Vaccine Innovation

  2021cites this paper
• Human Natural Antibodies to Mammalian Carbohydrate Antigens as Unsung Heroes Protecting against Past, Present, and Future Viral Infections

  2020cites this paper
• Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2

  2020cites this paper
• SARS‐CoV‐2 replicating in nonprimate mammalian cells probably have critical advantages for COVID‐19 vaccines due to anti‐Gal antibodies: A minireview and proposals

  2020cites this paper
• Possible Link Between the ABO Blood Group of Bioprosthesis Recipients and Specific Types of Structural Degeneration

  2020cites this paper
• Distribution of Bacterial α1,3-Galactosyltransferase Genes in the Human Gut Microbiome

  2020cites this paper
• Host Synthesized Carbohydrate Antigens on Viral Glycoproteins as “Achilles’ Heel” of Viruses Contributing to Anti-Viral Immune Protection

  2020cites this paper
• COVID-19 in the Developing World: Is the Immune Response to α-Gal an Overlooked Factor Mitigating the Severity of Infection?

  2020cites this paper
• A dataset for the analysis of antibody response to glycan alpha-Gal in individuals with immune-mediated disorders

  2020cites this paper
• Quantitative and qualitative changes in anti‐Neu5Gc antibody response following rabbit anti‐thymocyte IgG induction in kidney allograft recipients

  2019cites this paper
• Immunogenicity Risks for Naturally Derived Complex Drugs

  2019cites this paper
• The Science and Regulations of Naturally Derived Complex Drugs

  2019cites this paper
• Recipients with blood group A associated with longer survival rates in cardiac valvular bioprostheses

  2019cites this paper
• Anti-Gal Comprises Most of Anti-Blood Group B Antibodies

  2018cites this paper
• Xenotransplantation and Kidney Regenerative Technology

  2017cites this paper
• Decrease of blood anti-α1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patients.

  2017cites this paper
• Anti-Gal and Anti-Neu5Gc Responses in Nonimmunosuppressed Patients After Treatment With Rabbit Antithymocyte Polyclonal IgGs

  2017cites this paper
• OriginalClinicalScienceçGeneral Anti-Gal and Anti-Neu 5 Gc Responses in Nonimmunosuppressed Patients After Treatment With Rabbit Antithymocyte Polyclonal IgGs

  2017influential citation
• Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma

  2016cites this paper
• Combination of cytokine-induced killer and dendritic cells pulsed with antigenic α-1,3-galactosyl epitope-enhanced lymphoma cell membrane for effective B-cell lymphoma immunotherapy.

  2016cites this paper
• Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival.

  2015cites this paper
• Significance of the Evolutionary α1,3-Galactosyltransferase (GGTA1) Gene Inactivation in Preventing Extinction of Apes and Old World Monkeys

  2014cites this paper
• Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors

  2014cites this paper
• Cell-Mediated Immunity and Vaccines

  2014cites this paper
• Burn Patients Treated with Porcine Skin Antigens without Transmission of PERV in Long-Term IgG Response to Porcine Neu5Gc

  2013cites this paper
• Anti-alpha-Gal antibody response following xenogeneic heart valve implantation in adults.

  2013cites this paper
• Long-Term IgG Response to Porcine Neu5Gc Antigens without Transmission of PERV in Burn Patients Treated with Porcine Skin Xenografts

  2013cites this paper
• Pancreatic carcinoma-specific immunotherapy using synthesised alpha-galactosyl epitope-activated immune responders: findings from a pilot study

  2013cites this paper
• IgE Production to α-Gal Is Accompanied by Elevated Levels of Specific IgG1 Antibodies and Low Amounts of IgE to Blood Group B

  2013cites this paper
• Is There a Correlation Between Anti-Pig Antibody Levels in Humans and Geographic Location During Childhood?

  2013cites this paper
• The effect of Gal ( 1 , 3 ) Gal glycopeptides-conjugates and human serum on HIV-1 infection and replication

  2012cites this paper
• The cloning , expression and characterisation of bacterial chitin-binding proteins from pseudomonas aeruginosa , serratia marcescens, photorhabdus luminescens and photorhabdus asymbiotica.

  2011influential citation
• Anti-Gal titers in healthy adults and inflammatory bowel disease patients.

  2011cites this paper
• Biological variation of anti-αGal-antibodies studied by a novel Time-Resolved ImmunoFluorometric Assay.

  2011influential citation
• Diversity of natural anti-α-galactosyl antibodies in human serum.

  2011cites this paper
• Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells.

  2011cites this paper
• Anti alpha-gal immune response following porcine bioprosthesis implantation in children.

  2010cites this paper
• Profiling human serum antibodies with a carbohydrate antigen microarray.

  2009cites this paper
• Progress towards clinical xenotransplantation.

  2008cites this paper
• Neutralization of HIV-1 by redirection of natural antibodies

  2008cites this paper
• Galα(1‐3)Gal expression of the cornea in vitro, in vivo and in xenotransplantation

  2007cites this paper
• Gal alpha(1-3)Gal expression of the cornea in vitro, in vivo and in xenotransplantation.

  2007cites this paper
• HUMAN ANTI-α-GALACTOSYL ANTIBODIES

  2007cites this paper
• Soluble Galα(1,3)Gal conjugate combined with hDAF preserves morphology and improves function of cardiac xenografts

  2007cites this paper
• Immune Complex Pathophysiology

  2007cites this paper
• Reactivity of Human Natural Antibodies to Endothelial Cells From Gal&agr;(1,3)Gal-Deficient Pigs

  2007cites this paper
• Reduced Fibrin Deposition and Intravascular Thrombosis in hDAF Transgenic Pig Hearts Perfused With Tirofiban

  2007cites this paper
• Serum anti-Glc(α1,4)Glc(α) antibodies as a biomarker for relapsing–remitting multiple sclerosis

  2006cites this paper
• Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.

  2006cites this paper
• Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis.

  2006cites this paper
• Serum Levels of Anti-αGalactosyl Antibodies Predict Survival and Peritoneal Dialysis–Related Enteric Peritonitis Rates in Patients Undergoing Renal Replacement Therapy

  2006cites this paper
• Anti-alpha-galactosyl antibodies recognizing epitopes terminating with alpha1,4-linked galactose: human natural and mouse monoclonal anti-NOR and anti-P1 antibodies.

  2005cites this paper
• Pigs as xenogeneic donors

  2005cites this paper
• The influence of natural antibody specificity on antigen immunogenicity

  2005cites this paper
• Evidence for Galalpha(1-3)Gal expression on primary porcine hepatocytes: implications for bioartificial liver systems.

  2005cites this paper
• Anti-α-galactosyl antibodies recognizing epitopes terminating with α1,4-linked galactose: human natural and mouse monoclonal anti-NOR and anti-P1 antibodies

  2005cites this paper
• Mice are unsuitable for modelling ABO discordance despite strain‐specific A cross‐reactive natural IgM

  2005cites this paper
• Non-specific removal of antibodies in patients with idiopathic dilated cardiomyopathy: implications for xenotransplantation.

  2004cites this paper
• Nature Bundles Immunoglobulin Iso-, Allo- and Idiotype to Target Adaptive Immune Response

  2004cites this paper
• Potential implications of ABO blood group for vascular rejection in pig to human kidney xenotransplantation

  2003cites this paper
• Presence of Gal‐α1,3Gal epitope on xenogeneic lines: implications for cellular gene therapy based on the encapsulation technology

  2003cites this paper
• Anti‐Galα1‐3Gal IgM and IgG antibody levels in sera of humans and old world non‐human primates

  2002cites this paper
• Anti-Gal alpha 1-3Gal IgM and IgG antibody levels in sera of humans and old world non-human primates.

  2002cites this paper
• Development and characterization of anti-Gal B cell receptor transgenic Gal−/− mice

  2002cites this paper
• Antibody-mediated activation of the classical complement pathway in xenograft rejection.

  2002cites this paper
• Human serum‐induced porcine endothelial cell E‐selectin expression is associated with IgG3 and IgM anti‐Gal antibodies

  2002cites this paper
• Anti‐pig antibody levels in naïve baboons and cynomolgus monkeys

  2002cites this paper
• Spectrotype analysis and clonal characteristics of human anti‐Gal alpha1–3Gal antibodies

  2002cites this paper
• Differences between synthetic oligosaccharide immunoabsorbents in depletion capacity for xenoreactive
anti‐Galα1–3Gal antibodies from human serum

  2001cites this paper
• Detection of xenoantibodies using a simple flow cytometric assay

  2001cites this paper
• Analysis of preformed xenoreactive antibodies in the discordant guinea pig to rat model using a guinea pig fibroblast-like cell line.

  2001cites this paper
• Both IgG and IgM anti‐pig antibodies induce complement activation and cytotoxicity

  2001cites this paper
• Analysis of preformed xenoreactive antibodies in the discordant guinea pig to rat model using a guinea pig fibroblast-like cell line

  2001cites this paper
• Literature update 1999, part 3. Xenotransplantation.

  2000cites this paper
• Anti-Galalpha1-3Gal IgM/IgG antibody levels in infants: do they have a clinical relevance in pediatric xenotransplantation?

  2000cites this paper
• Literature update 1999, part 3

  2000cites this paper
• Literature update 1999, part 2

  1999cites this paper
• The Human Response to Endotoxin

  1998cites this paper